Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3- (2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells

Journal of Neuro-Oncology

Volumn 79, Issue 3, 2006, Pages 271-279

  Nakagawa, Takao ^a   Kubota, Toshihiko ^a   Ido, Kazunori ^a   Sakuma, Takahiro ^a   Matsuda, Ken ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

ACNU; cDNA array; Drug resistance; Glial marker; Glioma

Indexed keywords

COMPLEMENTARY DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NESTIN; NIMUSTINE; PERIPHERAL MYELIN PROTEIN 22; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLEIOTROPHIN; PROTEOCHONDROITIN SULFATE; STEM CELL FACTOR; VIMENTIN;

ANIMAL CELL; ARTICLE; CANCER RECURRENCE; CANCER RESISTANCE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; GLIOMA CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MACROGLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; IMMUNOHISTOCHEMISTRY; NIMUSTINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748567140     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9143-z     Document Type: Article

References (24)

1. Louis DN, Pomeroy SL, Caircross JQ (2002) Focus on central nervous system neoplasia. Cancer Cell 1:125-128
2. Saito R, Bringas J, Mirek H, Berger MS, Bankiewicz KS (2004) Invasive phenotype observed in 1,3- bis (2-chloroethyl)-1-nitrosourea-resistant sublines of 9 L rat glioma cells: A tumor model mimicking a recurrent malignant glioma. J Neurosurg 101:826-831
3. Bredel M, Zentner J (2002) Brain-tumour drug resistance: The bare essentials. Lancet Oncol 3:397-406
4. Norman SA, Rhodes SN, Treasurywala S, Hoelzinger DB, Rankin Shapiro J, Scheck AC (2000) Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display. Cancer 89:850-862
5. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64:53-57
6. Shibui S (2004) Japan Clinical Oncology Group-Brain Tumor Study Group: Randomized controlled trial on malignant brain tumors - activities of the Japan Clinical Oncology Group-Brain Tumor Study Group. Neurol Med Chir (Tokyo) 44:220-221
7. Nakayama H, Yokoi H, Fujita J (1992) Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res 20:4939
8. Nakagawa T, Yabe T, Schwartz JP (2005) Gene expression profiles of reactive astrocytes cultured from dopamine-depleted striatum. Neurobiol Dis 20:275-282
9. Nakagawa T, Schwartz JP (2004) Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol 14:275-280
10. Ida JA Jr, Dubois-Dalcq M, McKinnon RD (1993) Expression of the receptor tyrosine kinase c-kit in oligodendrocyte progenitor cells. J Neurosci Res 36:596-606
11. Hall A, Giese NA, Richardson WD (1996) Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors. Development 122:4085-4094
12. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996) Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314
13. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996) Interaction between NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells is required for optimal response to PDGF. J Neurosci Res 43:315-330
14. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A, Watson MA (2002) Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 62:2085-2091
15. Bloch B, Normand E, Kovesdi I, Bohlen P (1992) Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: An in situ hybridization study. Brain Res Dev Brain Res 70:267-278
16. Nakagawa T, Schwartz JP (2004) Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int 45:203-242
17. Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J, Baumann NA (1978) Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci 35:147-155
18. van der Meulen JD, Houthoff HJ, Ebels EJ (1978) Glial fibrillary acidic protein in human gliomas. Neuropathol Appl Neurobiol 4:177-190
19. Velasco ME, Dahl D, Roessmann U, Gambetti P (1980) Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer 45:484-494
20. Tascos NA, Parr J, Gonatas NK (1982) Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system. Hum Pathol 13:454-458
21. Hara A, Sakai N, Yamada H, Niikawa S, Ohno T, Tanaka T, Mori H (1991) Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining. Surg Neurol 36:190-194
22. Kajiwara K, Orita T, Nishizaki T, Kamiryo T, Nakayama H, Ito H (1992) Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas. Brain Res 572:314-318
23. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7-16
24. Bandres E, Andion E, Escalada A, Honorato B, Catalan V, Cubedo E, Cordeu L, Garcia F, Zarate R, Zabalegui N, Garcia-Foncillas J (2005) Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol 73:189-198